Effect of atazanavir and ritonavir on the differentiation and adipokine secretion of human subcutaneous and omental preadipocytes

AIDS

Volumn 22, Issue 11, 2008, Pages 1293-1298

  Jones, Simon P ^a   Waitt, Catriona ^a   Sutton, Robert ^a   Back, David J ^a   Pirmohamed, Munir ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ATAZANAVIR; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; LEPTIN; RITONAVIR; OLIGOPEPTIDE; PROTEINASE INHIBITOR; PYRIDINE DERIVATIVE;

ADULT; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CYTOKINE RELEASE; DRUG EFFECT; DRUG EXPOSURE; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; LIPID METABOLISM; LIPODYSTROPHY; MALE; OMENTUM; PATHOGENESIS; PRIORITY JOURNAL; PROADIPOCYTE; STAINING; ADIPOCYTE; AGED; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; METABOLISM; MIDDLE AGED; SUBCUTANEOUS FAT;

ADIPOCYTES; ADIPOKINES; ADULT; AGED; CELL DIFFERENTIATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HIV PROTEASE INHIBITORS; HUMANS; MALE; MIDDLE AGED; OLIGOPEPTIDES; OMENTUM; PYRIDINES; RITONAVIR; SUBCUTANEOUS FAT;

EID: 49849095230     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283021a4f     Document Type: Article

References (37)

1. Bergman RN, Van Citters GW, Mittelman SD, Dea MK, Hamilton-Wessler M, Kim SP, Ellmerer M. Central role of the adipocyte in the metabolic syndrome. J Investig Med 2001; 49:119-126.
2. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, Cooper DA. Fatigue effects on muscle excitability. AIDS 1998; 12:F51-F58.
3. Ahima RS, Flier JS. Adiposetissueasanendocrineorgan. Trends Endocrinol Metab 2000; 11:327-332.
4. Wajchenberg BL, Giannella-Neto D, da Silva ME, Santos RF. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res 2002; 34:616-621.
5. Tchkonia T, Giorgadze N, Pirtskhalava T, Tchoukalova Y, Karagiannides I, Forse RA, et al. Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am J Physiol Regul Integr Comp Physiol 2002; 282:R1286-R1296.
6. Arner P. The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab 2003; 14:137-145.
7. Edens NK, Fried SK, Kral JG, Hirsch J, Leibel RL. In vitro lipid synthesis in human adipose tissue from three abdominal sites. Am J Physiol 1993; 265 (3 Pt 1):E374-E379.
8. Niesler CU, Siddle K, PrinsJB. Human preadipocytes display a depot-specific susceptibility to apoptosis. Diabetes 1998; 47: 1365-1368.
9. Mal lon PW, MillerJ, Cooper DA, Carr A. Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1 -infected men starting therapy. AIDS 2003; 17:971 -979.
10. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinology 2004; 219:9-15.
11. Altmann SW, Timans JC, Rock FL, Bazan JF, Kastelein RA. Expression and purification of a synthetic human obese gene product. Protein Expr Purif 1995; 6:722-726.
12. Halleux CM, Takahashi M, Delporte ML, Detry R, Funahashi T, Matsuzawa Y, Brichard SM. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun 2001; 288:1102-1107.
13. Mynarcik D, Wei LX, Komaroff E, Ferris R, McNurlan M, Gelato M. Loss of subcutaneous adipose tissue in HIV-associated lipodystrophy is not due to accelerated apoptosis. J Acquir Immune Defic Syndr 2005; 38:53-56.
14. Addy CL, Gavrila A, Tsiodras S, Brodovicz K, Karchmer AW, Mantzoros CS. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy. J Clin Endocrinol Metab 2003; 88:627-636.
15. Jones SP, Janneh O, Back DJ, Pirmohamed M. Altered adipokine response in murine 3T3-F442A adipocytes treated with protease inhibitors and nucleoside reverse transcriptase inhibitors. Antivir Ther 2005; 10:207-213.
16. Vernochet C, Azoulay S, Duval D, Guedj R, Cottrez F, Vidal H, Ailhaud G, Dani C. Human immunodeficiency virus protease inhibitors accumulate into cultured human adipocytes and alter expression of adipocytokines. J Biol Chem 2005; 280:2238-2243.
17. Wentworth JM, Burris TP, Chatterjee VK. HIV protease inhibitors block human preadipocyte differentiation, but not via the PPARgamma/RXR heterodimer. J Endocrinol 2000; 164:R7-R10.
18. Johnson M, Grinsztejn B, Rodriguez C, Coco J, Dejesus E, Lazzarin A, et al. Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures. AIDS 2005; 19:153-162.
19. Hauner H, Skurk T, Wabitsch M. Cultures of human adipose precursor cells. Methods Mol Biol 2001; 155:239-247.
20. Hauner H, Entenmann G, Wabitsch M, Gail lard D, Ailhaud G, Negrel R, Pfeiffer EF. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest 1989; 84:1663-1670.
21. Parker RA, FlintOP, Mulvey R, Elosua C, Wang F, Fenderson W, Wang S, Yang WP, Noor MA. Endoplasmic reticulum stress links dyslipidemia to inhibition of proteasome activity and glucose transport by HIV protease inhibitors. Mol Pharmacol 2005; 67:1909-1919.
22. Dowell P, FlexnerC, Kwiterovich PO, Lane MD. Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors. J Biol Chem 2000; 275:41325-41332.
23. Jones SP, Janneh O, Maher B, Khoo S, Back D, Pirmohamed M. Antivir Ther 2002; 10:207-213.
24. Bastard JP, Caron M, Vidal H, Jan V, Auclair M, Vigouroux C, et al. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Lancet 2002; 359:1026-1031.
25. Bacchetti P, Gripshover B, Grunfeld C, Heymsfield S, McCreath H, Osmond D, et al. Genetic characterization of full-length HIV type 1 genomes from 3 infected paid blood donors in Henan, China. J Acquir Immune Defic Syndr 2005; 40:121-131.
26. Gougeon ML, Penicaud L, Fromenty B, Leclercq P, Viard JP, Capeau J. Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations. Antivir Ther 2004; 9:161-177.
27. Lagathu C, Kim M, Maachi M, Vigouroux C, Cervera P, Capeau J, et al. HIV antiretroviral treatment alters adipokine expression and insulin sensitivity of adipose tissue in vitro and in vivo. Biochimie 2005; 87:65-71.
28. Lihn AS, Richelsen B, Pedersen SB, Haugaard SB, Rathje GS, Madsbad S, Andersen O. Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels. Am J Physiol Endocrinol Metab 2003; 285:E1072-E1080.
29. Lindegaard B, Keller P, Bruunsgaard H, Gerstoft J, Pedersen BK. Low plasma level of adiponectin is associated with stavudine treatment and lipodystrophy in HIV-infected patients. Clin Exp Immunol 2004; 135:273-279.
30. Lihn AS, Pedersen SB, Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 2005; 6:13-21.
31. Kim R, Wilson C, Wabitsh M, Lazar M, Steppan C. HIV protease inhibitor-specific alterations in human adipocyte differentiation and metabolism. Obesity (Silver Spring) 2006; 14:994-1002.
32. van Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F, Arner P. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998; 47:913-917.
33. van Harmelen V, Dicker A, Ryden M, Hauner H, Lonnqvist F, Naslund E, Arner P. Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes 2002; 51:2029-2036.
34. Vigouroux C, Maachi M, Nguyen TH, Coussieu C, Gharakha-nian S, Funahashi T, et al. Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy. AIDS 2003; 17:1503-1511.
35. Estrada V, Serrano-Rios M, Martinez Larrad MT, Villar NG, Gonzalez Lopez A, Tellez MJ, Fernandez C. Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 29:32-40.
36. Xu A, Yin S, Wong L, Chan KW, Lam KS. Adiponectin ameliorates dyslipidemia induced by the human immunodeficiency virus protease inhibitor ritonavir in mice. Endocrinology 2004; 145:487-494.
37. Jan V, Cervera P, Maachi M, Baudrimont M, Kim M, Vidal H, Girard PM, Levan P, Rozenbaum W, Lombes A, Capeau J, Bastard JP. Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1 -infected lipodystrophic patients. Antivir Ther 2004; 9:555-564.